According to Kenya Bureau of Standards (KEBS), now Kenyans who like taking indomie will continue consuming it. KEBS has recently revealed that, indomie sold in various shops in Kenya does not have excessive aflotoxins as reports earlier, meaning human beings can use it as food.
This reports comes, when it was earlier said that the indomie had much aflatoxins for human consumption that led the product to be banned by many countries including Kenya.
Confirming the new information about indomie, Bernard Njiraini the KEBS managing director, said that samples that was taken for analysis had no aflotoxins substance making the products ideal for human consumption.
"We took samples of Indomie in our labs, we did an analysis and we found low contents of aflotoxins that does not have effects to human beings," Bernard was quot
He added that the level of poison in the indomie was too low to cause human being harm thus Kenyans can continue consuming the products.
Content created and supplied by: Daddiz (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More